<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04534309</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00229163</org_study_id>
    <nct_id>NCT04534309</nct_id>
  </id_info>
  <brief_title>Behavioral Weight Loss Program for Cancer Survivors in Maryland</brief_title>
  <acronym>ASPIRE</acronym>
  <official_title>Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maryland Cigarette Restitution Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration&#xD;
      Project&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the ASPIRE Project is to design, implement, and evaluate a real-world,&#xD;
      lifestyle-based, support for overweight or obese cancer survivors in both urban and rural&#xD;
      areas of Maryland. The project will provide three options of support to encourage lifestyle&#xD;
      change to achieve and maintain a healthy weight for cancer survivors:&#xD;
&#xD;
        1. Self-Directed Weight Loss: educational materials only;&#xD;
&#xD;
        2. App-Directed Weight Loss: educational materials, weight loss app with weekly e-mail&#xD;
           support; and&#xD;
&#xD;
        3. Coach-Directed Weight Loss: educational materials, weight loss app, weekly e-mail&#xD;
           support and one-to-one weekly telephonic coach support.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight change at 6 months in Coach-Directed Program</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Evaluate the &quot;effectiveness&quot; of the Coach-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 6-months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight change at 6 months in Self-Directed and App-Directed Weight Loss Programs</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Evaluate the &quot;effectiveness&quot; of the Self-Directed and App-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 6-months.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Program participation as assessed by participant enrollment</measure>
    <time_frame>End of enrollment, up to 2 years</time_frame>
    <description>Examine the enrollment in each program as a measure of program participation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adoption of weight loss program activities as assessed by app use frequency</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate the &quot;adoption&quot; of the App-Directed Weight Loss Program and Coach-Directed Weight Loss Program by examining app-use frequency at six months.</description>
  </other_outcome>
  <other_outcome>
    <measure>Implementation of weight loss program as assessed by a participant survey</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate the implementation of the Coach-Directed Weight Loss Program through a participant survey.</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight change at 12 months by program</measure>
    <time_frame>Baseline and 12 months</time_frame>
    <description>Evaluate the &quot;maintenance&quot; of the Self-Directed, App-Directed and Coach-Directed weight loss programs in a real world setting by examining weight change [in kilograms (kg)] at 12-months by program.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Prostate Cancer</condition>
  <condition>Melanoma (Skin)</condition>
  <condition>Endometrial Cancer</condition>
  <condition>Gallbladder Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Kidney Cancer</condition>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Self-Directed Weight Loss with year-long weight tracking</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Written Weight Loss Material.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>App-Directed Weight Loss with year-long weight tracking</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Smart phone Weight Loss App.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coach-Directed Weight Loss with year-long weight tracking</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Behavioral Lifestyle Weight Loss Intervention with Smart phone Weight Loss App.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written Weight Loss Material</intervention_name>
    <description>Participants will receive written weight loss material by email.</description>
    <arm_group_label>Self-Directed Weight Loss with year-long weight tracking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Weight Loss App</intervention_name>
    <description>Participants will receive written weight loss material as well as instructions for using a free weight loss app on their phone or computer.</description>
    <arm_group_label>App-Directed Weight Loss with year-long weight tracking</arm_group_label>
    <arm_group_label>Coach-Directed Weight Loss with year-long weight tracking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Lifestyle Weight Loss Intervention (Coaching)</intervention_name>
    <description>Participants will receive weekly coaching phone calls to encourage regular dietary, exercise, and self-monitoring practices which encourage gradual, healthy weight loss.</description>
    <arm_group_label>Coach-Directed Weight Loss with year-long weight tracking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  previously diagnosed with a malignant solid tumor,&#xD;
&#xD;
          -  completed all required surgical, and/or chemotherapy and/or radiation curative intent&#xD;
             therapy at least three months prior to enrollment,&#xD;
&#xD;
          -  anticipated treatment-free life span of 12 months or longer.&#xD;
&#xD;
          -  chemoprophylaxis with tamoxifen or aromatase inhibitors for breast cancer in women&#xD;
             will be permitted&#xD;
&#xD;
          -  anti- Luteinizing-hormone releasing therapy for prostate cancer in men will be&#xD;
             permitted.&#xD;
&#xD;
          -  BMI ≥ 25 kg/m2 (BMI ≥ 23 kg/m2 for Asians) and weight ≤ 400 lbs.&#xD;
&#xD;
          -  have an email address for regular personal use&#xD;
&#xD;
        Additional criteria for participants in weight tracking (self-directed or app directed)&#xD;
&#xD;
          -  willingness to record/transmit quarterly weights for 12 months&#xD;
&#xD;
        Additional criteria for App-Directed Program:&#xD;
&#xD;
          -  willingness to change diet and increase physical activity and track weight, diet and&#xD;
             physical activity&#xD;
&#xD;
          -  have a smart phone for personal use&#xD;
&#xD;
          -  sufficient data plan/Internet to support daily use of weight loss app*&#xD;
&#xD;
        Additional Criteria for Coach-Directed Weight Loss Program&#xD;
&#xD;
          -  willingness to lose weight by changing diet and physical activity habits&#xD;
&#xD;
          -  willingness to track weight, diet and physical activity&#xD;
&#xD;
          -  willingness to record/transmit quarterly weights for 12 months&#xD;
&#xD;
          -  smart phone for personal use&#xD;
&#xD;
          -  data plan/Internet to support daily use of weight loss app*&#xD;
&#xD;
          -  willingness to complete coaching calls (12 weekly calls and 3 monthly calls)&#xD;
&#xD;
          -  sufficient call plan to support coaching calls&#xD;
&#xD;
               -  a corresponding website could be used, then daily Internet access is required for&#xD;
                  person use.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  received any chemotherapy (unless anti-hormonal therapy) and/or radiation three months&#xD;
             or less prior to the proposed program date&#xD;
&#xD;
          -  women who are breastfeeding, pregnant, or planning pregnancy within the next year&#xD;
&#xD;
        Additional exclusion criteria for participants in weight tracking and/or Coach-Directed&#xD;
        Program&#xD;
&#xD;
          -  self-identification of uncontrolled concurrent medical condition likely to limit&#xD;
             compliance with the program as determined by investigators.&#xD;
&#xD;
          -  current involvement in another organized weight loss program&#xD;
&#xD;
          -  current use of steroids or other medication known to affect body weight&#xD;
&#xD;
          -  bariatric surgery scheduled within the next 6 months, or&#xD;
&#xD;
          -  plan to move outside the continental US in the next 12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica Yeh, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Yeh, Ph.D.</last_name>
    <phone>410-281-6100</phone>
    <email>hyeh1@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda Bunyard, MS, RD</last_name>
    <phone>410-281-6168</phone>
    <email>lbunyar1@jh.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins ProHealth</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bunyard</last_name>
      <phone>410-281-1600</phone>
      <email>aspirestudy@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jeanne Charleston</last_name>
      <phone>410-281-1600</phone>
      <email>jeannec@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jessica Yeh, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Gallbladder Neoplasms</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

